My friends, On April 24, stocks took a bit of a hit. It wasn’t a crash by any stretch of the imagination; the losses weren’t even enough to lead anyone’s news broadcast that evening. There was no Big… Read More
Analyst Articles
I’m Taking My Profits On This Holding
April 24, 2018
My friends, I’m exiting Ripple. We’ve inked a gain of about 14% in six weeks (more than 100% annualized), and it’s time to seek greener pastures. As Bitcoin faltered, Ripple did as I expected and rose. For those of you who… Read More
Welcome To The Party, Mr. Speaker
April 19, 2018
My friends, In the last issue, we learned a few basics about nanotechnology — the manipulation of matter on a molecular scale — an application that I think is going to yield some impressive, knock-the-cover-off-the-ball gains in the next decade. One of… Read More
My friends, I want to tell you about something that’s coming next. Come to think of it, that’s pretty much my job around here. And sometimes I get so charged up about things that I just can’t wait for an issue or an update… Read More
For an update on the special report that I promised — “Three Big Winners Overlooked By Wall Street” — scroll to the bottom or click here. Spoiler alert: I’m almost finished, and this will be worth the wait. My friends,… Read More
I’m Doubling Down
April 4, 2018
My friends, When my dad took me to Omaha for my first shareholder’s meeting, I was amazed. Warren Buffett stood in front of God and everyone in attendance and told us about every mistake that he had made that year. In detail. And he… Read More
My friends, Welcome to your Fast-Track Millionaire “update” issue. I’m glad you’re here. My time is valuable and so is yours, and I’m not here to waste either. But there’s just way too much good stuff carefully stacked in curated piles on… Read More
Your Questions, My Answers
March 14, 2018
My friends, It doesn’t happen very often, but: I’m truly humbled. And nearly speechless. The response to Fast-Track Millionaire has been phenomenal. I’ve received a number of great comments and questions from you, my charter subscribers. I trust these will prove highly… Read More
Biopharmaceutical company CRISPR Therapeutics (Nasdaq: CRSP) released fourth-quarter and full-year results last Thursday and the Street just went nuts. Shares, which had trended higher since my initial recommendation in the premiere issue of Fast-Track Millionaire earlier in the week, popped from their… Read More
My friends, I’ve been writing about investing for a long time. I’ve made a ton of money for a lot of people. I’ve picked a long string of winners, many returning triple digits — Tesla (up 840.8%), Adobe (up… Read More